| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,041,415 | 1,754,484 | 1,564,886 | 1,788,743 | | Cost of Revenue | 1,118,596 | 988,573 | 955,320 | 1,128,191 | | | Gross Profit | 922,819 | 765,911 | 609,566 | 660,552 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 179,778 | 141,510 | 166,724 | 173,888 | | Non Recurring |
-
|
-
|
-
| 1,168,900 | | Others | 499,050 | 479,350 | 489,828 | 535,449 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 243,991 | 145,051 | (46,986) | (1,217,685) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,066 | 49,511 | 2,021 | 4,352 | | Earnings Before Interest And Taxes | 245,057 | 194,562 | (44,965) | (1,213,333) | | Interest Expense | 169,294 | 163,835 | 165,109 | 232,799 | | Income Before Tax | 75,763 | 30,727 | (210,074) | (1,446,132) | | Income Tax Expense | 6,792 | 22,989 | (49,654) | (232,819) | | Minority Interest | (11,408) |
-
|
-
| (4,640) | | | | Net Income From Continuing Ops | 57,563 | 7,738 | (160,420) | (1,217,953) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 57,563 | 7,738 | (160,420) | (1,217,953) | | Preferred Stock And Other Adjustments | 6,965 | (3,876) | (3,089) |
-
| | | Net Income Applicable To Common Shares | $64,528 | $3,862 | ($163,509) | ($1,217,953) |
|
1.25% Nasdaq 
Income Statement
